Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Massachusetts Eye and Ear Infirmary
ClinicalTrials.gov Identifier:
NCT00765921
First received: October 2, 2008
Last updated: June 14, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2016
  Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)